ArticleOncoTargets and therapy2016

Monitoring of high-density lipoprotein cholesterol level is predictive of EGFR mutation and efficacy of EGFR-TKI in patients with advanced lung adenocarcinoma.

Yang Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.